Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-02

Clinical Trial Update: Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing vinflunine plus capecitabine versus capecitabine alone in advanced breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Vinflunine (vinflunine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Malignant Neoplasm of Breast | Phase 3 | Status: COMPLETED | Results posted: 2019-05-02